Pharming Group NV
NASDAQ:PHAR

Watchlist Manager
Pharming Group NV Logo
Pharming Group NV
NASDAQ:PHAR
Watchlist
Price: 18.09 USD 4.93%
Market Cap: 1.2B USD

Wall Street
Price Targets

PHAR Price Targets Summary
Pharming Group NV

Wall Street analysts forecast PHAR stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for PHAR is 17.73 USD with a low forecast of 17.14 USD and a high forecast of 18.74 USD.

Lowest
Price Target
17.14 USD
5% Downside
Average
Price Target
17.73 USD
2% Downside
Highest
Price Target
18.74 USD
4% Upside
Pharming Group NV Competitors:
Price Targets
BBIO
BridgeBio Pharma Inc
12% Upside
IMMU
Mendus AB (publ)
227% Upside
PHM
Pharma Mar SA
30% Upside
688266
Suzhou Zelgen Biopharmaceuticals Co Ltd
48% Upside
002675
Yantai Dongcheng Biochemicals Co Ltd
29% Upside
TLX
Telix Pharmaceuticals Ltd
128% Upside
IPH
Innate Pharma SA
223% Upside

Revenue
Forecast

Revenue Estimate
Pharming Group NV

For the last 13 years the compound annual growth rate for Pharming Group NV's revenue is 42%. The projected CAGR for the next 4 years is 8%.

42%
Past Growth
8%
Estimated Growth
Estimates Accuracy
-7%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Pharming Group NV

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-18%
Average Miss

Net Income
Forecast

Net Income Estimate
Pharming Group NV

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-29%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is PHAR's stock price target?
Price Target
17.73 USD

According to Wall Street analysts, the average 1-year price target for PHAR is 17.73 USD with a low forecast of 17.14 USD and a high forecast of 18.74 USD.

What is Pharming Group NV's Revenue forecast?
Projected CAGR
8%

For the last 13 years the compound annual growth rate for Pharming Group NV's revenue is 42%. The projected CAGR for the next 4 years is 8%.

Back to Top